Solventum Corporation

SOLV · NYSE · USD

Historical Earnings

QuarterReportedEPS estEPS actSurpriseRev estRev actSurpriseReaction
Q2 2026Aug 5, 20261.902.55+34.2%$2.2B$2.2B+2.6%−5.16%
Q1 2026May 5, 20261.351.48+9.6%$2.0B$2.0B+2.0%+2.82%
Q4 2025Feb 26, 20261.501.57+4.7%$2.0B$2.0B+1.8%−3.56%
Q3 2025Nov 6, 20251.431.50+4.9%$2.1B$2.1B+2.0%+7.91%
Q2 2025Aug 7, 20251.451.69+16.6%$2.1B$2.2B+2.0%+2.00%
Q1 2025May 8, 20251.211.34+10.7%$2.0B$2.1B+2.7%+5.40%
Q4 2024Feb 27, 20251.311.41+7.6%$2.1B$2.1B+1.1%−4.42%
Q3 2024Nov 7, 20241.391.64+18.0%$2.1B$2.1B+1.2%−3.52%

Detailed View

Q3 2026Nov 5, 2026Q2 2026Aug 5, 2026−5.16%Q1 2026May 5, 2026+2.82%Q4 2025Feb 26, 2026−3.56%Q3 2025Nov 6, 2025+7.91%Q2 2025Aug 7, 2025+2.00%Q1 2025May 8, 2025+5.40%Q4 2024Feb 27, 2025−4.42%Q3 2024Nov 7, 2024−3.52%Q2 2024Aug 8, 2024Q1 2024May 9, 2024Q4 2023Mar 11, 2024
2026 Q2 Metrics
MetricEstimateActualSurpriseY/Y
Revenue$2.2B$2.2BBeat +2.55%+2.2%
EPS1.902.55Beat +34.21%+50.9%
Diluted EPS (GAAP)—0.53—+3.9%
Documents